Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients

NCT05343832 is registered in ClinicalTrials.gov with Genetron Health as lead sponsor.

NCT NCT05343832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
Lead sponsor
Genetron Health
Phase
Observational
Overall status
Unknown status
Start date
November 29, 2021
Completion date
April 25, 2023
Enrollment
4,816 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer